Outcomes After Transcatheter Closure of Atrial Septal Defect Without Using a Balloon-Sizing Technique: A Randomized Controlled Comparison with Closures Using a Balloon-Sizing Technique

ASD Device Closure without Balloon Sizing

Authors

  • Beom Joon Kim, MD Department of Pediatrics, Catholic University, Eunpyeong St. Mary’s Hospital Seoul
  • Jinyoung Song, MD, PhD Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • June Huh, MD, PhD Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • I-Seok Kang, MD Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

DOI:

https://doi.org/10.1532/hsf.4571

Keywords:

Atrial septal defect, catheterization closure devices, size perception

Abstract

Background: The transcatheter closure of atrial septal defect could be completed without the balloon-sizing technique, so we evaluated long-term outcomes compared with closure using balloon sizing, which was the conventional method. Even without using the balloon-sizing technique, transcatheter closure of atrial septal defect might be safe and effective.

Methods: We included 124 patients with isolated atrial septal defects who underwent device closure without balloon sizing between 2012 and 2016, and we further included 257 patients as a control group. Patients who received closure with multiple devices or who experienced postoperative residual defects were excluded. Immediate procedural results, as well as long-term outcomes for closure without balloon sizing, were investigated and compared with the control group.

Results: The procedural success rate was 96.7%, and there were no mortalities. No embolization or cardiac erosions were observed; however, one patient experienced residual shunt, and another developed progressed mitral regurgitation during the follow-up period (983±682 days). Newly onset persistent atrial fibrillation developed in one patient (1.0%). There were no significant differences in procedures or follow-up between the study and control groups. Despite the shorter procedural time in the study group, fluoro time was not different. Atrial arrhythmias were more frequently observed in the control group, but the difference was not significant. Persistent atrial fibrillation was observed in two patients in the control group (0.8%).

Conclusions: Transcatheter closure of atrial septal defect can be performed safely and effectively without using the balloon-sizing technique. The long-term outcomes were similar to outcomes with balloon sizing.

References

Alqahtani F, Bhirud A, Aljohani S, et al. 2017. Intracardiac versus transesophageal echocardiography to guide transcatheter closure of interatrial communications: Nationwide trend and comparative analysis. J Interv Cardiol. 30:234-41.

Alsaileek AA, Omran A, Godman M, Najm HK. 2007. Echocardiographic visualization of laceration of atrial septum during balloon sizing of the atrial septal defect. Eur J Echocardiogr. 8:155-7.

Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. 2004. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv. 63:496-502.

Aytemir K, Oto A, Ozkutlu S, et al. 2013. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results. Congenit Heart Dis. 8:418-27.

Carlson KM, Justino H, O'Brien RE, et al. 2005. Transcatheter atrial septal defect closure: modified balloon sizing technique to avoid overstretching the defect and oversizing the Amplatzer septal occluder. Catheter Cardiovasc Interv. 66:390-6.

Diab KA, Cao QL, Bacha EA, Hijazi ZM. 2007. Device closure of atrial septal defects with the Amplatzer septal occluder: safety and outcome in infants. J Thorac Cardiovasc Surg. 134:960-6.

Ewert P, Berger F, Daehnert I, Krings G, Dittrich S, Lange PE. 2000. Diagnostic catheterization and balloon sizing of atrial septal defects by echocardiographic guidance without fluoroscopy. Echocardiography. 17:159-63.

German C, Nanda NC. 2015. Three-dimensional echocardiographic assessment of atrial septal defects. Ann Card Anaesth. 18:69-73.

Godart F, Rey C, Francart C, Jarrar M, Vaksmann G. 1993. Two-dimensional echocardiographic and color Doppler measurements of atrial septal defect, and comparison with the balloon-stretched diameter. Am J Cardiol. 72:1095-7.

Jalal Z, Hascoet S, Baruteau AE, et al. 2016. Long-term Complications After Transcatheter Atrial Septal Defect Closure: A Review of the Medical Literature. Can J Cardiol. 32:1315 e11-15 e18.

Jone PN, Zablah JE, Burkett DA, et al. 2018. Three-Dimensional Echocardiographic Guidance of Right Heart Catheterization Decreases Radiation Exposure in Atrial Septal Defect Closures. J Am Soc Echocardiogr. 31:1044-49.

Kitakata H, Itabashi Y, Kanazawa H, et al. 2021. Appropriate device selection for transcatheter atrial septal defect closure using three-dimensional transesophageal echocardiography. Int J Cardiovasc Imaging. 37:1159-68.

Nyboe C, Olsen MS, Nielsen-Kudsk JE, Hjortdal VE. 2015. Atrial fibrillation and stroke in adult patients with atrial septal defect and the long-term effect of closure. Heart. 101:706-11.

Osawa K, Miyoshi T, Morimitsu Y, et al. 2015. Comprehensive assessment of morphology and severity of atrial septal defects in adults by CT. J Cardiovasc Comput Tomogr. 9:354-61.

Patel A, Cao QL, Koenig PR, Hijazi ZM. 2006. Intracardiac echocardiography to guide closure of atrial septal defects in children less than 15 kilograms. Catheter Cardiovasc Interv. 68:287-91.

Quek SC, Wu WX, Chan KY, Ho TF, Yip WC. 2010. Transcatheter closure of atrial septal defects--is balloon sizing still necessary? Ann Acad Med Singap. 39:390-3.

Rajiah P, Schoenhagen P. 2013. The role of computed tomography in pre-procedural planning of cardiovascular surgery and intervention. Insights Imaging. 4:671-89.

Rigatelli G, Cardaioli P, Hijazi ZM. 2007. Contemporary clinical management of atrial septal defects in the adult. Expert Rev Cardiovasc Ther. 5:1135-46.

Rigatelli G, Cardaioli P, Roncon L, et al. 2007. Impact of intracardiac echocardiography on radiation exposure during adult congenital heart disease catheter-based interventions. Int J Cardiovasc Imaging. 23:139-42.

Rigatelli G, Dell'avvocata F, Cardaioli P, et al. 2012. Safety and long-term outcome of modified intracardiac echocardiography-assisted "no-balloon" sizing technique for transcatheter closure of ostium secundum atrial septal defect. J Interv Cardiol. 25:628-34.

Rigatelli G, Nghia NT, Zuin M, Conte L, D'Elia K, Nanjundappa A. 2019. Very long-term outcomes of transcatheter secundum atrial septal defect closure using intracardiac echocardiography without balloon sizing. Clin Radiol. 74:732 e17-32 e22.

Salehian O, Horlick E, Schwerzmann M, et al. 2005. Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. J Am Coll Cardiol. 45:499-504.

Villablanca PA, Briston DA, Rodes-Cabau J, et al. 2017. Treatment options for the closure of secundum atrial septal defects: A systematic review and meta-analysis. Int J Cardiol. 241:149-55.

Wang JK, Tsai SK, Lin SM, Chiu SN, Lin MT, Wu MH. 2008. Transcatheter closure of atrial septal defect without balloon sizing. Catheter Cardiovasc Interv. 71:214-21.

Published

2022-04-22

How to Cite

Kim, B. J. ., Song, J., Huh, J. ., & Kang, I.-S. (2022). Outcomes After Transcatheter Closure of Atrial Septal Defect Without Using a Balloon-Sizing Technique: A Randomized Controlled Comparison with Closures Using a Balloon-Sizing Technique: ASD Device Closure without Balloon Sizing. The Heart Surgery Forum, 25(2), E288-E293. https://doi.org/10.1532/hsf.4571

Issue

Vol. 25 No. 2 (2022)

Section

Articles

Author Disclosure & Copyright Transfer Agreement

In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.

A current form follows:

The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.

However, Publisher grants back to the author(s) the following:

  1. The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
  2. The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
  3. The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
  4. The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
  5. The right to make oral presentations of material from this work.

Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.

I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.

I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).

I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.

Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).